Nectero Medical, Inc.

Nectero Medical is a clinical-stage biotech company focused on developing novel therapies for aneurysmal disease. Their flagship product, the Nectero EAST® System, is an investigational treatment that aims to stabilize the growth of small to mid-sized abdominal aortic aneurysms (AAA), potentially preventing rupture and delaying the need for major interventions like surgery. This minimally invasive system delivers a proprietary mixture containing pentagalloyl glucose (PGG) directly to the aneurysm site via a catheter.

The company is led by a highly experienced management team and board of directors with extensive expertise in therapeutic device development and vascular medicine. Nectero Medical has secured significant funding through multiple financing rounds, including a recent $96M Series D, and has received both Fast Track and Breakthrough Therapy designations from the FDA for the Nectero EAST® System. These accolades highlight the potential of their treatment and the company's commitment to bring transformative therapies to patients with aneurysmal disease.

Nectero Medical does not explicitly state their job flexibility policies on their website or in their job postings.

Nectero Medical offers competitive compensation and benefits to its employees, including support for employee learning, growth, and advancement. They are an Equal Opportunity Employer. While the specific benefits are not listed, their commitment to employee development and advancement suggests a focus on employee well-being.

Nectero Medical is a clinical-stage biotech company dedicated to revolutionizing the treatment of aneurysmal disease. The company's vision is to transform lives by pioneering novel therapies that stabilize growth, prevent rupture, and ultimately improve the quality of life for patients living with aneurysms. Their primary focus is on developing the Nectero EAST® System, a minimally invasive endovascular treatment for small to mid-sized abdominal aortic aneurysms, which currently lacks any proven therapeutic options.

Nectero Medical promotes a team-oriented culture that values collaboration, innovation, and integrity. They emphasize the importance of working together towards a common goal, delivering creative solutions, and upholding ethical standards in all their endeavors. They are committed to supporting employee learning, growth, and advancement through competitive compensation and benefits, creating an inclusive and supportive work environment for all.

Nectero Medical is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives. The company actively supports employee learning, growth, and advancement, provides competitive compensation and benefits, and promotes a culture of collaboration and respect. Nectero Medical is an Equal Opportunity Employer and encourages applications from individuals of all backgrounds.